The coordinated development mode of biopharmaceutical industry-university-research: an investigation
based on the experience in the development of biopharmaceutical industry in Zhejiang Province
CHENG Yongwei1, 2, FENG Xiaochu2.
1.School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China; 2.Pharmaceutical Valley (Wenzhou) Technology Development Co., LTD, Wenzhou 325035, China
CHENG Yongwei,FENG Xiaochu. The coordinated development mode of biopharmaceutical industry-university-research: an investigation
based on the experience in the development of biopharmaceutical industry in Zhejiang Province[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2023, 53(12): 1028-1032,封三.
Abstract：China has stepped into the “14th Five-Year Plan” period of high-quality development. By April 2023, nearly 490 biopharmaceutical enterprises have been listed in China’s A-share market, with a total market value of approximately 7.29 trillion yuan. Considered as an emerging industry of strategic significance in the 14th Five-Year Plan, biopharmaceutical industry is expected to become an important support for the public healthcare in the future. At present, Zhejiang Province, compared with other regions in China, has stronger pharmaceutical innovation capacity. However, some deficiencies were found in the aspects of collaborative development and model innovation. This research, combining the practical and empirical research paradigm proceeded from the reality, will share literature analysis, theoretical analysis and empirical analysis, by which we mean to provide suggestions for building a modern pharmaceutical collaborative innovation system that would be able to realize self-generating and virtuous cycle development, with a view to promoting the coordinated development of biopharmaceutical industry-university-research.
